These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 6545585)
1. [Critical evaluation of the causes of death in thalassemic subjects]. Boffa C; Merisio MG; Rivolta S; Fontanelli G; Franchi E; Terzoli S; Stucchi C Pediatr Med Chir; 1984; 6(6):755-8. PubMed ID: 6545585 [TBL] [Abstract][Full Text] [Related]
2. [Yersinia enterocolitica sepsis in splenectomized thalassemic subjects. Description of 2 cases]. Rasore-Quartino A; Mattiello A; Cominetti M; Casini Lemmi M; Traverso T; Sansone G Pediatr Med Chir; 1986; 8(1):121-4. PubMed ID: 3725604 [TBL] [Abstract][Full Text] [Related]
3. The correlation of transferrin saturation and ferritin in non-splenectomized thalassemic children. Wangruangsathit S; Hathirat P; Chuansumrit A; Pakakasama S; Hongeng S J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S74-6. PubMed ID: 10730522 [TBL] [Abstract][Full Text] [Related]
4. Severe iron overload in Blackfan-Diamond anemia: a case-control study. Roggero S; Quarello P; Vinciguerra T; Longo F; Piga A; Ramenghi U Am J Hematol; 2009 Nov; 84(11):729-32. PubMed ID: 19810012 [TBL] [Abstract][Full Text] [Related]
5. Iron status and anemia in thalassemic Sardinian carriers. Pardini S; Dore F; Oggiano L; Bonfigli S; Pacifico S; Campus S; Longinotti M Haematologica; 1986; 71(1):17-9. PubMed ID: 3084350 [No Abstract] [Full Text] [Related]
6. Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload. Fung EB; Harmatz P; Milet M; Ballas SK; De Castro L; Hagar W; Owen W; Olivieri N; Smith-Whitley K; Darbari D; Wang W; Vichinsky E; Am J Hematol; 2007 Apr; 82(4):255-65. PubMed ID: 17094096 [TBL] [Abstract][Full Text] [Related]
8. [Chelating therapy in beta-thalassemia]. Musumeci S; Romeo MA; Di Gregorio F; Schiliró G; Russo G Pediatr Med Chir; 1982; 4(1-2):55-9. PubMed ID: 7111040 [TBL] [Abstract][Full Text] [Related]
9. [Trend in mortality of Mediterranean anemia in Italy]. Mastroeni I; Tarsitani G Minerva Med; 1981 Mar; 72(11):662-70. PubMed ID: 7243011 [No Abstract] [Full Text] [Related]
10. Bone marrow transplantation in class 2 thalassemia patients. Giardini C; Galimberti M; Lucarelli G; Polchi P; Baronciani D; Angelucci E Bone Marrow Transplant; 1993; 12 Suppl 1():59-62. PubMed ID: 8374566 [No Abstract] [Full Text] [Related]
11. Survival and complications in thalassemia. Borgna-Pignatti C; Cappellini MD; De Stefano P; Del Vecchio GC; Forni GL; Gamberini MR; Ghilardi R; Origa R; Piga A; Romeo MA; Zhao H; Cnaan A Ann N Y Acad Sci; 2005; 1054():40-7. PubMed ID: 16339650 [TBL] [Abstract][Full Text] [Related]
12. Longitudinal study of survival and causes of death in patients with thalassemia major in Greece. Ladis V; Chouliaras G; Berdousi H; Kanavakis E; Kattamis C Ann N Y Acad Sci; 2005; 1054():445-50. PubMed ID: 16339695 [TBL] [Abstract][Full Text] [Related]
13. Echocardiographic study in ex-thalassemic patients with iron overload, preliminary observations during phlebotomy therapy. Mariotti E; Agostini A; Angelucci E; Lucarelli G; Sgarbi E Bone Marrow Transplant; 1993; 12 Suppl 1():106-7. PubMed ID: 8374547 [TBL] [Abstract][Full Text] [Related]
14. The validity of pallor as a clinical sign of anemia in cases with beta-thalassemia. Yalçin SS; Unal S; Gümrük F; Yurdakök K Turk J Pediatr; 2007; 49(4):408-12. PubMed ID: 18246743 [TBL] [Abstract][Full Text] [Related]
15. High nontransferrin bound iron levels and heart disease in thalassemia major. Piga A; Longo F; Duca L; Roggero S; Vinciguerra T; Calabrese R; Hershko C; Cappellini MD Am J Hematol; 2009 Jan; 84(1):29-33. PubMed ID: 19006228 [TBL] [Abstract][Full Text] [Related]
16. Incidence and outcome of Yersinia enterocolitica infection in thalassemic patients. Cherchi GB; Cossellu S; Pacifico L; Gallisai D; Ranucci A; Zanetti S; Fadda G; Chiesa C Contrib Microbiol Immunol; 1995; 13():16-8. PubMed ID: 8833786 [No Abstract] [Full Text] [Related]
17. The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron? Silverberg DS; Wexler D; Iaina A J Nephrol; 2004; 17(6):749-61. PubMed ID: 15593047 [TBL] [Abstract][Full Text] [Related]
18. Non cardiopatic and cardiopatic beta thalassemic patients: quantitative and qualitative cardiac iron deposition evaluation with MRI. Macarini L; Marini S; Pietrapertosa A; Scardapane A; Ettorre GC Radiol Med; 2005; 109(1-2):77-90. PubMed ID: 15729188 [TBL] [Abstract][Full Text] [Related]
19. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Borgna-Pignatti C; Rugolotto S; De Stefano P; Zhao H; Cappellini MD; Del Vecchio GC; Romeo MA; Forni GL; Gamberini MR; Ghilardi R; Piga A; Cnaan A Haematologica; 2004 Oct; 89(10):1187-93. PubMed ID: 15477202 [TBL] [Abstract][Full Text] [Related]
20. A severe case of Yersinia enterocolitica infection in a thalassemic patient. Perniola R; Petracca M; De Rinaldis C; Perrone A; Pizzolante M Ital J Gastroenterol Hepatol; 1997 Feb; 29(1):82-3. PubMed ID: 9265586 [No Abstract] [Full Text] [Related] [Next] [New Search]